Cargando…

Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy

INTRODUCTION: Lymphangioma are rare vascular malformation that results from maldevelopment of primitive lymphatic sacs. They are most frequently found in the neck and axilla, while intra-abdominal and mediastinal lymphangiomas are uncommon. Atypical site of cystic hygroma in pediatric age group are...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatnagar, Ankur, Upadhyaya, Vijai Datta, Yadav, Rajnikant, Kumar, Basant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051672/
https://www.ncbi.nlm.nih.gov/pubmed/33897180
http://dx.doi.org/10.4103/njms.NJMS_48_20
_version_ 1783679778579021824
author Bhatnagar, Ankur
Upadhyaya, Vijai Datta
Yadav, Rajnikant
Kumar, Basant
author_facet Bhatnagar, Ankur
Upadhyaya, Vijai Datta
Yadav, Rajnikant
Kumar, Basant
author_sort Bhatnagar, Ankur
collection PubMed
description INTRODUCTION: Lymphangioma are rare vascular malformation that results from maldevelopment of primitive lymphatic sacs. They are most frequently found in the neck and axilla, while intra-abdominal and mediastinal lymphangiomas are uncommon. Atypical site of cystic hygroma in pediatric age group are usually difficult to diagnose clinically but can be diagnosed easily by ultrasound. The aim of the study was to evaluate the result of the intralesional bleomycin for macrocystic lymphatic malformation (LM) presenting at atypical site MATERIAL AND METHOD: All patients of LM of other than head& neck, axilla and abdomen presenting in pediatric age group were included in the study. Mainstay of diagnosis was ultrasound and was supplemented by CT scan wherever required. All patients were managed with intralesional bleomycin (ILB) and surgical excision was done only if primary therapy failed. RESULT: Total 15 cases of LM presenting at atypical sites were included in the study. Series include two case of cystic hygroma of breast, 4 cases of cystic hygroma of anterior chest wall, two case of substernal LM, three cases of LM of parotid gland, one case of inguinal region cystic hygroma and 4 cases involving submandicular area. Complete resolution was observed in 13 out of 15 cases, and two cases had less than 50% reduction in size and were managed with surgical excision after second session of ILB. CONCLUSION: Aqueous Intralesional bleomycin is a cost effective alternative to surgery even at rare sites of LM which provide better aesthetic outcome, and avoids complication associated with surgery.
format Online
Article
Text
id pubmed-8051672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80516722021-04-23 Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy Bhatnagar, Ankur Upadhyaya, Vijai Datta Yadav, Rajnikant Kumar, Basant Natl J Maxillofac Surg Original Article INTRODUCTION: Lymphangioma are rare vascular malformation that results from maldevelopment of primitive lymphatic sacs. They are most frequently found in the neck and axilla, while intra-abdominal and mediastinal lymphangiomas are uncommon. Atypical site of cystic hygroma in pediatric age group are usually difficult to diagnose clinically but can be diagnosed easily by ultrasound. The aim of the study was to evaluate the result of the intralesional bleomycin for macrocystic lymphatic malformation (LM) presenting at atypical site MATERIAL AND METHOD: All patients of LM of other than head& neck, axilla and abdomen presenting in pediatric age group were included in the study. Mainstay of diagnosis was ultrasound and was supplemented by CT scan wherever required. All patients were managed with intralesional bleomycin (ILB) and surgical excision was done only if primary therapy failed. RESULT: Total 15 cases of LM presenting at atypical sites were included in the study. Series include two case of cystic hygroma of breast, 4 cases of cystic hygroma of anterior chest wall, two case of substernal LM, three cases of LM of parotid gland, one case of inguinal region cystic hygroma and 4 cases involving submandicular area. Complete resolution was observed in 13 out of 15 cases, and two cases had less than 50% reduction in size and were managed with surgical excision after second session of ILB. CONCLUSION: Aqueous Intralesional bleomycin is a cost effective alternative to surgery even at rare sites of LM which provide better aesthetic outcome, and avoids complication associated with surgery. Wolters Kluwer - Medknow 2020 2020-12-16 /pmc/articles/PMC8051672/ /pubmed/33897180 http://dx.doi.org/10.4103/njms.NJMS_48_20 Text en Copyright: © 2020 National Journal of Maxillofacial Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bhatnagar, Ankur
Upadhyaya, Vijai Datta
Yadav, Rajnikant
Kumar, Basant
Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title_full Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title_fullStr Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title_full_unstemmed Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title_short Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
title_sort management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051672/
https://www.ncbi.nlm.nih.gov/pubmed/33897180
http://dx.doi.org/10.4103/njms.NJMS_48_20
work_keys_str_mv AT bhatnagarankur managementofmacrocysticlymphaticmalformationatuncommonsitewithaqueousbleomycinsclerotherapy
AT upadhyayavijaidatta managementofmacrocysticlymphaticmalformationatuncommonsitewithaqueousbleomycinsclerotherapy
AT yadavrajnikant managementofmacrocysticlymphaticmalformationatuncommonsitewithaqueousbleomycinsclerotherapy
AT kumarbasant managementofmacrocysticlymphaticmalformationatuncommonsitewithaqueousbleomycinsclerotherapy